VialAOD9604 5 mg vial
Fat metabolism
Investigated for lipid metabolism signaling.
- Ships from Canada in 1–2 business days
- Free shipping over $120
Place your order, then send the e-Transfer. We pack it as soon as it arrives.
For research use only. Not for human consumption.
Complete your setup
Needles and wipes are free. Water is $19.
- Bacteriostatic Water
$19.00 · To reconstitute the powder
- Needles
Free · For reconstitution
- Alcohol Wipes
Free · To prep the vial stopper
About AOD9604
AOD 9604 is a synthetic peptide derived from the C-terminal fragment of human growth hormone, isolated for research into fat metabolism without the broader activity of the full hormone.
How it works
- GH Fragment
- Studied as a specific fragment of growth hormone, isolated to narrow the research focus to metabolic pathways.
- Lipid Metabolism
- Explored in research on fat metabolism signaling without the systemic profile of the full hormone.
What you need
- Bacteriostatic Water
- Needles
- Alcohol Wipes
- A protocol guide comes with every order
Shipping & payment
- Packed and dispatched within 1–2 business days
- Delivered across Canada in 2–5 business days, tracked
- Temperature-controlled packaging where the product needs it
- Free shipping on orders over $120
- Prices in CAD · pay by Interac e-Transfer
- Format
- Lyophilised powder in a sealed vial
- Strength
- 5 mg per vial
- Storage
- Refrigerate, away from light. Once reconstituted, keep refrigerated and use within the window on the insert.
- Reconstitution
- 2 mL bacteriostatic water for this 5 mg vial (2.5 mg/mL)
- Route in research
- Subcutaneous
- SKU
- 5AD
Handling
- 1ReconstituteAdd bacteriostatic water down the side of the vial. Swirl, never shake. Agitation damages the peptide chain.
- 2StoreRefrigerate at 2–8°C once mixed. Reconstituted peptide is stable for the window given in your protocol guide.
- 3Measure with the calculator Use an insulin syringe at the units your protocol specifies. Rotate sites and log what you take.
- Purity
- High-performance liquid chromatography (HPLC), by an independent laboratory
- Identity
- Mass spectrometry, on the same batch
- How often
- Every batch
- COA
- The certificate of analysis is matched to the lot code printed on your vial
- Evidence
- Early clinical
Check your lot
Every vial carries a lot code. Enter it, or scan the QR on the label, to see its expiry and certificate of analysis.
Early clinicalAOD-9604 has been reviewed as an investigational metabolic and anti-obesity compound in clinical development, but no late-stage trial results or regulatory approvals are documented here.
What research examines
- Fat metabolism and lipolysis signaling
- Investigational anti-obesity research
- Metabolic activity separated from full growth hormone effects
- Detection and in vitro metabolism in anti-doping science
- Interaction with growth hormone isoform immunoassays
Reported in studies
- Human safety data are limited
- Adverse events are not summarized in the cited studies
- Described as lacking the growth hormone regions tied to growth and glucose handling
- Reported not to affect IGF-1 in its research profile
- Studied in anti-doping detection contexts
Published research protocols
300 mcg, daily, am fasted
Research protocols have used 250–500 mcg per administration, once daily (morning, fasted), in 12-week blocks with 4 weeks off.
For research use only. These figures summarize published research protocols. They are not instructions or medical advice.
Measure with the calculatorCoreX AI
Ask about AOD9604
Plain answers, from the basics to the studies.
Research information, not medical advice.
Often researched with AOD9604
Researched for weight & body composition.
Vial
Vial
Vial
FAQ
Questions, answered
AOD-9604 is a synthetic peptide derived from the C-terminal fragment of human growth hormone. It was isolated to support research into fat metabolism without the broader activity of the full hormone. It is often described as a metabolic fragment, and it has been reviewed in the literature as an investigational compound in metabolic and obesity-related research. CoreX supplies AOD-9604 for laboratory research use only.
Research describes AOD-9604 as retaining the portion of the growth hormone molecule associated with lipolysis while lacking the regions tied to growth and glucose handling. This narrower structure lets researchers study fat metabolism signaling without the systemic profile of the full hormone. Its research profile is characterized as direct lipolysis with no IGF-1 impact, which distinguishes it from full-length growth hormone in experimental work.
AOD-9604 has been studied mainly for its role in lipid metabolism and as an investigational anti-obesity compound, with reviews covering its metabolic profile. Separate analytical work has examined how it can be detected, how it is metabolized in vitro, and whether it interferes with the anti-doping growth hormone isoform immunoassay. One study reported that AOD-9604 does not influence that immunoassay.
Human safety data for AOD-9604 are limited, and adverse events are not summarized in the cited studies. Its research profile is described as lacking the growth hormone regions associated with growth and glucose handling, and as having no impact on IGF-1. Because published safety information is sparse, conclusions about tolerability should be drawn cautiously and only from primary study reports.
Research protocols have used 250 to 500 mcg per administration, once daily in the morning under fasted conditions, delivered subcutaneously. These protocols have run in 12-week blocks followed by 4 weeks off. These figures describe published or reported research designs only and are not recommendations. Each CoreX order ships with a protocol guide for laboratory reference.
You may also like
Vial · Pen
Vial · Pen
Vial
Vial

